on NANOBIOTIX (EPA:NANO)
NANOBIOTIX plans to participate in investor conferences
Nanobiotix, a French biotechnology company, has announced its participation in several investor conferences in November. These events will take place in London. The Jefferies Global Healthcare Conference will be held on March 10, 2026, while the UBS Global Biopharma Conference is scheduled for November 17, 2026.
The presentation at the Jefferies Global Healthcare Conference will include a fireside chat with Laurent Levy and Arnd Christ, respectively co-founder and CEO, and CFO of Nanobiotix. The company hopes to showcase its developments, focused on the innovative use of nanoparticles in the treatment of cancer and other diseases. Nanobiotix is listed on Euronext Paris and the NASDAQ Global Select Market.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NANOBIOTIX news